NDC 72579-121

Tevimbra 10 mg per 1 mL injection, solution, concentrate

On the label: BeOne Medicines USA, Inc..

China: 1Switzerland: 1Slovenia: 1

Where it's made

FactoryWhereRoleLast FDA inspection
Boehringer Ingelheim Biopharmaceuticals (China) Ltd.Shanghai, ChinaMakes it, makes the active ingredient and tests it Not inspected on record
Novartis Pharma Stein AGStein, SwitzerlandMakes it and tests it Problems found, fixed voluntarilyJul 19, 2024 · 9 inspections
Novartis d.o.o.Menges, SloveniaMakes the active ingredient and tests it No problems foundSep 21, 2022 · 6 inspections
BeOne Pharmaceutical (Suzhou) Co.,LtdSuzhou, ChinaTests it Problems found, fixed voluntarilyJun 16, 2023 · 1 inspection
Bioreliance Ltd.Glasgow Lanarkshire, United KingdomTests it Problems found, fixed voluntarilyMay 13, 2026 · 7 inspections
Lek d.d.Ljubljana, SloveniaTests it Problems found, fixed voluntarilyNov 18, 2025 · 9 inspections
Microcoat Biotechnologie GmbHBernried, GermanyTests it Problems found, fixed voluntarilyJun 27, 2024 · 2 inspections
Sharp Packaging Services, LLCMacungie, PA, United StatesPackages it and labels it Problems found, fixed voluntarilySep 12, 2025 · 6 inspections

Product details

Generic drug
Tislelizumab: every company that makes it
Form
injection, solution, concentrate, intravenous
Strength
10 mg per 1 mL
Approval
BLA BLA761232
On the market since
Mar 14, 2024
Package NDCs
72579-121-01
Official label
DailyMed (National Library of Medicine), updated Sep 1, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?